comparemela.com

Paul Matteis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA analysis raises no major concerns about Eli Lilly Alzheimer s drug

An FDA analysis of trial data for Eli Lilly s experimental Alzheimer s drug donanemab released on Thursday revealed no red flags, but raised questions about safety of the treatment for patients with early-stage disease.

Xenon Pharmaceuticals Inc (NASDAQ:XENE) Q1 2024 Earnings Call Transcript

Xenon Pharmaceuticals Inc (NASDAQ:XENE) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

vimarsana © 2020. All Rights Reserved.